Skip to main content

Rezira FDA Approval History

FDA Approved: Yes (First approved June 8, 2011)
Brand name: Rezira
Generic name: hydrocodone and pseudoephedrine
Dosage form: Oral Solution
Company: Cypress Pharmaceutical, Inc.
Treatment for: Cough and Nasal Congestion

Rezira (hydrocodone and pseudoephedrine) Oral Solution is a combination product containing an antitussive and nasal decongestant indicated for the relief of cough and nasal congestion associated with the common cold.

Development timeline for Rezira

Jun 23, 2011Approval FDA Approves Rezira (hydrocodone bitartrate and pseudoephedrine HCl) Oral Solution

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.